BACKGROUND: Being able to identify patients at risk of exacerbations is useful as it enables resources to be targeted at these patients. AIMS: To test the theoretically-derived prediction that the frequency of non-asthma related visits to the general practitioner (GP) predicts exacerbations. METHODS: Clinical and demographic data and both self-report and prescription-based adherence data were obtained from 166 patients diagnosed with asthma attending a GP clinic, all of whom were prescribed inhaled corticosteroids (ICS). Asthma exacerbations (treated by the GP or in hospital) and non-asthma visits and symptoms were assessed from notes for the subsequent 5 years. RESULTS: Exacerbations correlated with non-asthma visits (0.35), severity as measured by BTS step (0.28), and with prescription-based adherence (0.28). Asthma severity correlated with non-asthma visits (0.35). Receiver operating curves showed that ≥2 non-asthma visits per year provided 79% sensitivity and 58% specificity for detecting ≥3 exacerbations over 5 years. Poor adherence predicted outcomes only for patients with high levels of non-asthma visits (≥3) and only for those reporting regular-but-less ICS use but not symptom-directed ICS use. CONCLUSIONS: Non-asthma visits are a good predictor of asthma exacerbations, particular in non-adherent patients. These results are consistent with a mechanism where exacerbations result from a combination of random oscillating specific and non-specific inflammatory processes. It is important to consider the total patient rather than just the lung when managing patients with asthma.
BACKGROUND: Being able to identify patients at risk of exacerbations is useful as it enables resources to be targeted at these patients. AIMS: To test the theoretically-derived prediction that the frequency of non-asthma related visits to the general practitioner (GP) predicts exacerbations. METHODS: Clinical and demographic data and both self-report and prescription-based adherence data were obtained from 166 patients diagnosed with asthma attending a GP clinic, all of whom were prescribed inhaled corticosteroids (ICS). Asthma exacerbations (treated by the GP or in hospital) and non-asthma visits and symptoms were assessed from notes for the subsequent 5 years. RESULTS: Exacerbations correlated with non-asthma visits (0.35), severity as measured by BTS step (0.28), and with prescription-based adherence (0.28). Asthma severity correlated with non-asthma visits (0.35). Receiver operating curves showed that ≥2 non-asthma visits per year provided 79% sensitivity and 58% specificity for detecting ≥3 exacerbations over 5 years. Poor adherence predicted outcomes only for patients with high levels of non-asthma visits (≥3) and only for those reporting regular-but-less ICS use but not symptom-directed ICS use. CONCLUSIONS: Non-asthma visits are a good predictor of asthma exacerbations, particular in non-adherent patients. These results are consistent with a mechanism where exacerbations result from a combination of random oscillating specific and non-specific inflammatory processes. It is important to consider the total patient rather than just the lung when managing patients with asthma.
Authors: Homer A Boushey; Christine A Sorkness; Tonya S King; Sean D Sullivan; John V Fahy; Stephen C Lazarus; Vernon M Chinchilli; Timothy J Craig; Emily A Dimango; Aaron Deykin; Joanne K Fagan; James E Fish; Jean G Ford; Monica Kraft; Robert F Lemanske; Frank T Leone; Richard J Martin; Elizabeth A Mauger; Gene R Pesola; Stephen P Peters; Nancy J Rollings; Stanley J Szefler; Michael E Wechsler; Elliot Israel Journal: N Engl J Med Date: 2005-04-14 Impact factor: 91.245
Authors: A ten Brinke; P J Sterk; A A M Masclee; P Spinhoven; J T Schmidt; A H Zwinderman; K F Rabe; E H Bel Journal: Eur Respir J Date: 2005-11 Impact factor: 16.671
Authors: Fernando D Martinez; Vernon M Chinchilli; Wayne J Morgan; Susan J Boehmer; Robert F Lemanske; David T Mauger; Robert C Strunk; Stanley J Szefler; Robert S Zeiger; Leonard B Bacharier; Elizabeth Bade; Ronina A Covar; Noah J Friedman; Theresa W Guilbert; Hengameh Heidarian-Raissy; H William Kelly; Jonathan Malka-Rais; Michael H Mellon; Christine A Sorkness; Lynn Taussig Journal: Lancet Date: 2011-02-14 Impact factor: 79.321
Authors: R A Joachim; O Noga; V Sagach; G Hanf; H Fliege; R D Kocalevent; E M Peters; B F Klapp Journal: Clin Exp Allergy Date: 2007-12-07 Impact factor: 5.018
Authors: Jacqueline Gamble; Michael Stevenson; Elizabeth McClean; Liam G Heaney Journal: Am J Respir Crit Care Med Date: 2009-07-30 Impact factor: 21.405
Authors: Michael E Hyland; Sue Blake; Colin J Greaves; Margaret Pinnuck; Clare Seamark; Dave Seamark; David Ward; David M G Halpin Journal: Prim Care Respir J Date: 2009-06
Authors: Gang Luo; Bryan L Stone; Michael D Johnson; Peter Tarczy-Hornoch; Adam B Wilcox; Sean D Mooney; Xiaoming Sheng; Peter J Haug; Flory L Nkoy Journal: JMIR Res Protoc Date: 2017-08-29